Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABMD | TMO | ISRG | EW | ALC |
| Company | Abiomed Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Alcon Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 380.78 | 580.17 | 385.55 | 87.63 | 81.13 |
| High | 381.28 | 594.03 | 389.76 | 88.09 | 82.08 |
| Low | 380.51 | 578.81 | 383.88 | 86.53 | 80.97 |
| Last | 381.02 | 593.03 | 386.70 | 86.72 | 82.01 |
| Change | +0.23 | +15.10 | +1.25 | -0.70 | +0.55 |
| % Change | +0.06% | +2.61% | +0.32% | -0.80% | +0.68% |
| Volume | 20,612,200 | 1,328,788 | 853,000 | 1,988,008 | 1,193,795 |
| 20-Day Average Volume | 2,182,260 | 1,520,870 | 1,409,650 | 2,873,645 | 799,120 |
| Previous Close | 380.79 | 577.93 | 385.45 | 87.42 | 81.46 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 379.15 | 567.35 | 376.91 | 86.60 | 79.71 |
| 20-Day Raw Stochastic | 85.14% | 98.45% | 80.12% | 39.13% | 90.67% |
| 20-Day Relative Strength | 74.25% | 60.67% | 53.85% | 47.29% | 54.12% |
| Weighted Alpha | 0.00 | +17.24 | +29.65 | +3.61 | +4.66 |
| Today's Opinion | 100% Buy | 80% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 88% Buy | 96% Buy | 80% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.24% since 12/14/22 | +3.61% since 05/03/24 | +1.40% since 05/03/24 | +1.72% since 05/03/24 | +3.07% since 05/03/24 |
| Low | 380.11 on 12/15/22 | 565.34 on 05/07/24 | 380.13 on 05/08/24 | 84.81 on 05/06/24 | 79.63 on 05/08/24 |
| High | 381.69 on 12/19/22 | 594.03 on 05/10/24 | 389.78 on 05/07/24 | 88.09 on 05/10/24 | 82.08 on 05/10/24 |
| 1-Month | |||||
| %Chg | +1.17% since 11/21/22 | +3.37% since 04/10/24 | -0.45% since 04/10/24 | -5.23% since 04/10/24 | -0.22% since 04/10/24 |
| Low | 376.55 on 12/02/22 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 77.54 on 04/30/24 |
| High | 381.80 on 12/08/22 | 594.03 on 05/10/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 82.68 on 04/11/24 |
| 3-Month | |||||
| %Chg | +50.71% since 09/21/22 | +7.68% since 02/09/24 | -0.39% since 02/09/24 | +2.01% since 02/09/24 | +6.23% since 02/09/24 |
| Low | 237.44 on 10/12/22 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 74.53 on 02/13/24 |
| High | 381.99 on 11/01/22 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 88.23 on 03/11/24 |
| 6-Month | |||||
| %Chg | +64.04% since 06/21/22 | +32.25% since 11/10/23 | +39.36% since 11/10/23 | +35.06% since 11/10/23 | +12.53% since 11/10/23 |
| Low | 227.02 on 06/22/22 | 439.11 on 11/13/23 | 281.12 on 11/13/23 | 64.07 on 11/13/23 | 69.53 on 11/16/23 |
| High | 381.99 on 11/01/22 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 88.23 on 03/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,180,568 | 220,605,120 | 136,719,120 | 52,679,288 | 40,167,924 |
| Shares Outstanding, K | 45,091 | 381,716 | 354,700 | 602,600 | 493,100 |
| Annual Sales | 1,031,750,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 9,455,000,000 |
| Annual Net Income | 136,510,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 974,000,000 |
| Last Quarter Sales | 265,920,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 2,352,000,000 |
| Last Quarter Net Income | 106,130,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 427,000,000 |
| 60-Month Beta | 1.40 | 0.80 | 1.39 | 1.10 | 0.92 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.30 on 11/01/22 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.70 on 02/27/24 |
| Latest Earnings Date | 02/02/23 | 04/24/24 | 04/18/24 | 04/25/24 | 05/14/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 78.68 | 26.53 | 81.28 | 33.37 | 29.22 |